In a patient suspected of Cushing's syndrome, what 8 a.m. serum cortisol level confirms autonomous cortisol excess, and what is the next step if the level is only mildly elevated?

8 AM Cortisol Levels in Cushing's Syndrome

An 8 AM serum cortisol level >1.8 μg/dL (50 nmol/L) after overnight 1-mg dexamethasone suppression test confirms autonomous cortisol excess and warrants further diagnostic workup, while mildly elevated levels between 1.8-5.0 μg/dL suggest mild autonomous cortisol secretion (MACS) requiring additional confirmatory testing with late-night salivary cortisol or 24-hour urinary free cortisol. 1

Diagnostic Thresholds for the 1-mg Dexamethasone Suppression Test

The overnight 1-mg dexamethasone suppression test (DST) is the primary screening tool for Cushing's syndrome. The patient takes 1 mg dexamethasone between 11 PM and midnight, and serum cortisol is measured at 8 AM the following morning.

Key Cutoff Values:

• <1.8 μg/dL (50 nmol/L): Normal suppression, effectively excludes Cushing's syndrome 1, 2
• >1.8 μg/dL (50 nmol/L): Abnormal suppression, indicates autonomous cortisol secretion 1, 2
• >5.0 μg/dL (138 nmol/L): Strongly suggests overt Cushing's syndrome, particularly in patients with adrenal incidentalomas 1

The 2021 Endocrine Society consensus emphasizes that cortisol <1.8 μg/dL has the highest negative predictive value and strongly excludes dysregulated cortisol production 1. However, recent evidence suggests the threshold may need adjustment based on clinical context—in adrenal incidentaloma patients, a cutoff of 196 nmol/L (approximately 7.1 μg/dL) may better differentiate true Cushing's syndrome from MACS 3.

Interpretation of Mildly Elevated Levels (1.8-5.0 μg/dL)

When the 8 AM post-dexamethasone cortisol falls in this intermediate range, you are dealing with mild autonomous cortisol secretion (MACS), not overt Cushing's syndrome. This requires a systematic approach:

Next Steps for Mildly Elevated Levels:

1. Perform additional screening tests to confirm autonomous cortisol production:

   • Late-night salivary cortisol (LNSC) - at least 2-3 samples 1
   • 24-hour urinary free cortisol (UFC) - at least 2-3 collections 1

2. Rule out false positives by checking for:

   • Medications that accelerate dexamethasone metabolism (phenobarbital, carbamazepine, St. John's wort) 1
   • Oral estrogens or pregnancy (increase cortisol-binding globulin) 1
   • Malabsorption conditions (celiac disease, chronic diarrhea) 1
   • Consider measuring dexamethasone levels to confirm adequate absorption 1

3. Assess for physiologic hypercortisolism (pseudo-Cushing's states):

   • Severe depression, anxiety, obsessive-compulsive disorder
   • Morbid obesity
   • Poorly controlled diabetes
   • Active alcoholism (requires ≥2 weeks abstinence before retesting) 2

Clinical Context Matters

The 2008 Endocrine Society guideline notes that the 1-mg DST has high sensitivity (>90%) but lower specificity, meaning false positives occur 2. The 48-hour low-dose dexamethasone test (0.5 mg every 6 hours for 48 hours) offers improved specificity and should be considered when the overnight test is equivocal, particularly in patients with psychiatric conditions or obesity 2.

Important Caveats:

• Cyclic Cushing's syndrome: Patients may have normal cortisol during quiescent periods. Multiple sequential tests over time are needed 1
• Immunoassay interference: Some platforms (e.g., Immulite 1000) can give spurious results. Mass spectrometry-based assays are more specific 4, 5
• MACS is common: Recent studies show abnormal suppression in approximately 25% of high-risk patients (resistant hypertension, treatment-resistant diabetes) 6

Algorithm for Action

For 8 AM cortisol <1.8 μg/dL: Stop workup, Cushing's syndrome excluded

For 8 AM cortisol 1.8-5.0 μg/dL:

• Order LNSC (×2-3) and UFC (×2-3)
• Review medications and exclude pseudo-Cushing's states
• If confirmatory tests abnormal → proceed to determine etiology (ACTH level, imaging)
• If confirmatory tests normal → consider cyclic disease, repeat testing in 3-6 months

For 8 AM cortisol >5.0 μg/dL:

• Proceed directly to confirmatory testing and etiology determination
• High likelihood of overt Cushing's syndrome requiring treatment

The threshold of 1.8 μg/dL remains the standard cutoff endorsed by major guidelines 1, 2, though emerging evidence suggests lower thresholds (around 1.2 μg/dL) may identify patients with cortisol-related comorbidities earlier, particularly in adrenal incidentaloma populations 7. However, lowering the threshold increases false positives and is not yet recommended for routine practice.